Octreotide therapy for chylous ascites in a chronic dialysis patient

Nephrology

Volumn 10, Issue 4, 2005, Pages 344-347

  Lee, Pei Hsien ^a   Lin, Chun Liang ^a   Lai, Ping Chin ^a   Yang, Chih Wei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chylous ascites; Octreotide; Peritoneal dialysis

Indexed keywords

OCTREOTIDE; PERITONEAL DIALYSIS FLUID;

ADULT; ARTICLE; CASE REPORT; CHYLOUS ASCITES; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALNUTRITION; PARENTERAL NUTRITION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

CATHETERIZATION; CHYLOUS ASCITES; FEMALE; HUMANS; MIDDLE AGED; OCTREOTIDE; PERITONEAL DIALYSIS;

EID: 28444433667     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00427.x     Document Type: Article

References (12)

1. Kjeldsberg C, Knight J. Body Fluid: Laboratory Examination of Cerebrospinal, Seminal, Serous and Synovial Fluid, 3rd edn. Chicago, IL: ASCP Press, 1993.
2. Laterre PF, Dugernier T, Reynaert MS. Chylous ascites: Diagnosis, causes and treatment. Acta Gastroenterol. Belg. 2000; 63: 260-3.
3. Garcia FT, Rodriguez-Carmona A, Perez FM et al. Complications of permanent catheter implantation for peritoneal dialysis: Incidence and risk factors. Adv. Perit. Dial. 1994; 10: 206-9.
4. Levy RI, Wenk RE. Chyloperitoneum in a peritoneal dialysis patient. Am. J. Kidney Dis. 2001; 38: E12.
5. Poux JM, Benevent D, Guiserix J, Le MY, Lagarde C, Leroux-Robert C. Chylous ascites in 12 patients undergoing peritoneal dialysis. Nephrologie 1994; 15: 201-5.
6. Porter J, Wang WM, Oliveira DB. Chylous ascites and continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 1991; 6: 659-61.
7. Leibovitch I, Mor Y, Golomb J, Ramon J. The diagnosis and management of postoperative chylous ascites. J. Urol. 2002; 167: 449-57.
8. Collard JM, Laterre PF, Boemer F, Reynaert M, Ponlot R. Conservative treatment of postsurgical lymphatic leaks with somatostatin-14. Chest 2000; 117: 902-5.
9. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N. Engl. J. Med. 1996; 334: 246-54.
10. Ulibarri JI, Sanz Y, Fuentes C, Mancha A, Aramendia M, Sanchez S. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 1990; 336: 258.
11. Shapiro AM, Bain VG, Sigalet DL, Kneteman NM. Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total patenteral nutrition. Transplantation 1996; 61: 1410-11.
12. Gunal AI, Celiker H, Akpolat N, Ustundag B, Duman S, Akcicek F. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution. Perit. Dial. Int. 2002; 22: 301-6.